Tags » Chronic Lymphocytic Leukemia

Clinical Care Options Article on Chronic Lymphocytic Leukemia

Clinical Care Options is an excellent educational website for physicians. I find their slides to be superb, and I use the slides to update myself on all the latest findings from the big meetings. 204 more words

Dr. Richard Furman Discusses Recent Changes in CLL Treatment

In this video clip from OncLive, Director of the CLL Research Center, Richard R. Furman, M.D. discusses the new treatments that have changed the care for patients with chronic lymphocytic leukemia (CLL).

Lymphoma News

Other People Get Cancer... Not Me!

One word… FEAR

After the CAT Scan showed an enlarged lymph node in my abdomen, I was referred to Dr. K., an Oncologist. Consultation, more labs, and a PET Scan was scheduled.  794 more words

Chronic Pain

Adding ibrutinib to bendamustine-rituximab in relapsed chronic lymphocytic leukemia

The annual meeting of the American Society of Clinical Oncology is underway in Chicago right now. The results of an important clinical trial were presented yesterday (Saturday, May 30, 2015). 479 more words

David Kranch (1941-2014) – Doting father and gran'pa loved family and Fords

By Tracey Powers and Alex Cierpicki

David Milton Kranch

Born: March 24th, 1941

Died: March 27th, 2014 in Ottawa of complications from chronic lymphocytic leukemia… 807 more words

Life Story

Ask the Doctor: Updates on Chronic Lymphocytic Leukemia & Small Lymphocytic Lymphoma

The Lymphoma Research Foundation’s (LRF) “Ask the Doctor About Lymphoma” programs are designed specifically for people affected by lymphoma. Tonight’s two-hour topic-specific seminar will feature a presentation led by Director of the CLL Research Center,  179 more words

Patient Education

FDA Grants Breakthrough Therapy Designation to Venetoclax for Patients with Relapsed/Refractory CLL with 17p Deletion

Earlier today the FDA granted the Breakthrough Therapy Designation to venetoclax (ABT-199). Venetoclax was awarded this designation for the treatment of relapsed or refractory CLL in previously treated patients with 17p deletion. 154 more words

Lymphoma News